Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EuroEyes International Eye Clinic Limited ( (HK:1846) ) just unveiled an update.
EuroEyes International Eye Clinic Limited reported a 5.6% increase in the total number of eye surgeries for the third quarter of 2025 compared to the same period in 2024, driven by a rise in lens exchange surgeries and a recovery in laser surgery volume. This growth indicates a positive trend in patient demand, enhancing the company’s performance and providing stakeholders with more comprehensive insights into its operational success.
The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, specializing in eye surgeries. The company focuses on procedures such as lens exchange and laser surgeries, catering to a growing patient demand.
Average Trading Volume: 194,654
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.02B
See more insights into 1846 stock on TipRanks’ Stock Analysis page.